thejoe Medaus, Inc.

Medaus, Inc.: 96 FDA recall reports

Every drug recall the FDA has published for Medaus, Inc.. The fault, and how the agency graded it.

96Reports

0Class I

0Ongoing

2016-07-20Most recent

What the classes mean

The FDA sorts every recall into one of three classes. The class is the whole story. It is also the part people skip.

Class	What the FDA is saying
Class I	There is a reasonable probability that using this will cause serious harm or death.
Class II	It may cause temporary or reversible harm. Serious harm is unlikely.
Class III	It breaks a rule but is unlikely to hurt anyone. Often a labelling fault.

Class II is the bulk of every list here. That matters. A long list of Class II says something different from one Class I.

By class

Class	Reports
Class II	95
Class III	1

By year reported

Year	Reports
2013	8
2016	88

Checking whether it affects you

The lot or code number is what matters. Not the product name. A recall covers specific lots. Yours may not be one of them.

Check the code on your package against the report. The FDA keeps the current list at fda.gov/safety/recalls.

The reports

The text below is quoted from the FDA record word for word.

M.I.C B-COMPLEX PREMIX W/HYDROXY B12 W/PRES. (BENZALKONIUM 0.01%) HYDROXY B12 1MG; B1 0.833MG; B2 0.083MG; B

D-1222-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: M.I.C B-COMPLEX PREMIX W/HYDROXY B12 W/PRES. (BENZALKONIUM 0.01%) HYDROXY B12 1MG; B1 0.833MG; B2 0.083MG; B3 0.833MG, B5 0.083MG, B6 0.083MG, CYANO B12 1.66MCG, METHIONINE 0.208MG, INOSITOL 0.416MG, CHOLINE CL 1.66MG/ML, 10ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 110 mL in Vials

M.I.C 25/50/50 W/PRES. (BENZYL ETOH 2%) METHIONINE 25MG;INOSITOL 50MG;CHOLINE CHL 50/MG/ML, In a) 5ML Vials a

D-1224-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: M.I.C 25/50/50 W/PRES. (BENZYL ETOH 2%) METHIONINE 25MG;INOSITOL 50MG;CHOLINE CHL 50/MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 500 mL in Vials

DEXPANTHENOL 250MG/ML W/PRES. (BENZALKONIUM CHL 0.01%), 10ML Vials, MEDAUS PHARMACY

D-1179-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: DEXPANTHENOL 250MG/ML W/PRES. (BENZALKONIUM CHL 0.01%), 10ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 1110 mL in Vials

L-GLUTATHIONE 100MG/ML (PF), 10 ML Vials, MEDAUS PHARMACY

D-1198-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: L-GLUTATHIONE 100MG/ML (PF), 10 ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 5000 mL in Vials

METHYL B12 10MG/ML (PF) IN NACL 0.9%, 1ML Vials, MEDAUS PHARMACY

D-1216-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: METHYL B12 10MG/ML (PF) IN NACL 0.9%, 1ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 1000 mL in Vials

L-CARNITINE 500MG/ML (PF), 10ML Vials, MEDAUS PHARMACY

D-1197-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: L-CARNITINE 500MG/ML (PF), 10ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 500 mL in Vials

MAGNESIUM CHL 200MG/ML (PF), In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY

D-1211-216 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: MAGNESIUM CHL 200MG/ML (PF), In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 5000 mL in Vials

METHYL B12 1000MCG/ML IN NACL 0.9% (PF), 2ML Vials, MEDAUS PHARMACY

D-1217-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: METHYL B12 1000MCG/ML IN NACL 0.9% (PF), 2ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 2000 mL in Vials

LIPO-INJECTION W/LIDOCAINE W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PO4-5MG, B-3-50MG, B5-5

D-1210-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: LIPO-INJECTION W/LIDOCAINE W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PO4-5MG, B-3-50MG, B5-5MG, B6-5MG, CYANO B12-100MCG, METHIONINE 12.5MG, INOSITOL 25MG, CHOLINE CHL-25MG, LIDOCAINE-10MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 14000 mL in Vials

B-COMPLEX 50 IN NACL 0.9% W/PRES., (BENZYL ETOH 2%), B1-50MG, B2-5-PO4-5MG, B3-50MG, B5-50MG, B6-50MG/ML, 10ML

D-1173-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: B-COMPLEX 50 IN NACL 0.9% W/PRES., (BENZYL ETOH 2%), B1-50MG, B2-5-PO4-5MG, B3-50MG, B5-50MG, B6-50MG/ML, 10ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 4000 mL in Vials

MINOXIDIL 0.5% W/PRES. (BENZYL ETOH 2%), 10ML Vials, MEDAUS PHARMACY

D-1226-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: MINOXIDIL 0.5% W/PRES. (BENZYL ETOH 2%), 10ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 21000 mL in Vials

PYRIDOXAL 50 MG/THIAMINE 50 MG/LIDOCAINE 1% NS (PF), 2ML Vials, MEDAUS PHARMACY

D-1234-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: PYRIDOXAL 50 MG/THIAMINE 50 MG/LIDOCAINE 1% NS (PF), 2ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 1000 mL in Vials

ARGININE 100MG/ML (PF), 10ML Vials, MEDAUS PHARMACY

D-1252-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: ARGININE 100MG/ML (PF), 10ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 1000 mL in Vials

MANGANESE SO4 0.1MG/ML (PF), In a) 2MLVials and b) 10ML Vials, MEDAUS PHARMACY

D-1213-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: MANGANESE SO4 0.1MG/ML (PF), In a) 2MLVials and b) 10ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 3000 mL in Vials

LIPO #4 W/METHYL B12 500 MCG/ML/NO METHIONINE W/PRES (BENZYL ETOH 2%) ASCORBIC ACID 50MG; B1-50MG;B2-5-P04-5M

D-1202-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: LIPO #4 W/METHYL B12 500 MCG/ML/NO METHIONINE W/PRES (BENZYL ETOH 2%) ASCORBIC ACID 50MG; B1-50MG;B2-5-P04-5MG;B3-30MG; B5-5MG;B6-5MG;METHYL B12 500 MCG; LIDOCAINE 10 MG; INOSITOL-25MG; CHOLINE CHL-25 MG/ML; 5ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 1000 mL in Vials

FOLIC ACID 10MG/ML W/PRES. (METHYLPARABEN 0.05%, PROPYLPARABEN 0.025% IN NACL, 10ML Vials, MEDAUS PHARMACY

D-1185-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: FOLIC ACID 10MG/ML W/PRES. (METHYLPARABEN 0.05%, PROPYLPARABEN 0.025% IN NACL, 10ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 500 mL in Vials

HYDROXY B12 5MG/ML IN NACL 0.9% (PF), In a) 1ML Vials and b) 2ML Vials, MEDAUS PHARMACY

D-1191-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: HYDROXY B12 5MG/ML IN NACL 0.9% (PF), In a) 1ML Vials and b) 2ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 800 mL in Vials

HYDROXY B12 1000MCG/ML IN NACL 0.9% (PF), 1ML Vials, MEDAUS PHARMACY

D-1193-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: HYDROXY B12 1000MCG/ML IN NACL 0.9% (PF), 1ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 300 mL in Vials

LIPO-BOOST W/PRES. (BENZYL ETOH 2%) B1-50MG, B2-5-PO4-2MG, B3-100MG, B5-2MG, B6-52MG, METHYL, B12-500MCG, CARN

D-1205-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: LIPO-BOOST W/PRES. (BENZYL ETOH 2%) B1-50MG, B2-5-PO4-2MG, B3-100MG, B5-2MG, B6-52MG, METHYL, B12-500MCG, CARNITINE 50 MG, METHIONINE 12.5MG, INOSITOL 25MG, CHOLINE CHL-25MG, LIDOCAINE 30MG/ML, In a) 3ML Vials and b) 5ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 65 mL in Vials

PYRIDOXINE HCL 100MG/ML W/PRES (BENZYL ETOH 0.02%), 5ML Vials, MEDAUS PHARMACY

D-1236-2016 · Class III · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: PYRIDOXINE HCL 100MG/ML W/PRES (BENZYL ETOH 0.02%), 5ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 4000 mL in Vials

NANDROLONE DEC 200MG/ML W/PRES. (BENZYL ETOH 10%), In a) 2ML Vials, b) 4ML Vials, and c) 5ML Vials, MEDAUS PHA

D-1230-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: NANDROLONE DEC 200MG/ML W/PRES. (BENZYL ETOH 10%), In a) 2ML Vials, b) 4ML Vials, and c) 5ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 400 mL in Vials

HYDROXY B12 5MG/ML W/PRES (BENZALKONIUM 0.01%), 5ML Vials, MEDAUS PHARMACY

D-1190-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: HYDROXY B12 5MG/ML W/PRES (BENZALKONIUM 0.01%), 5ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 210 mL in Vials

EDTA DISODIUM 15% (150MG/ML), 20ML Vials, MEDAUS PHARMACY

D-1182-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: EDTA DISODIUM 15% (150MG/ML), 20ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 24000 mL in Vials

HCL 2MG/ML (PF), 5ML Vials, MEDAUS PHARMACY

D-1254-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: HCL 2MG/ML (PF), 5ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 1000 mL in Vials

B-COMPLEX #3 W/PRES (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-100MG, B5-2MG, B6-2MG/ML, 10ML Vials, MEDAUS

D-1168-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: B-COMPLEX #3 W/PRES (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-100MG, B5-2MG, B6-2MG/ML, 10ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 380 mL in Vials

LIPO W/LIDOCAINE #3 W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID 50MG; B1-50MG;B2-5-P04-5MG;D3-30MG; B5-5MG;B6-5MG;C

D-1201-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: LIPO W/LIDOCAINE #3 W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID 50MG; B1-50MG;B2-5-P04-5MG;D3-30MG; B5-5MG;B6-5MG;CYANO B12-1MG; METHIONINE 12.5MG; INOSITOL-25MG; CHOLINE CL-25 MG; LIDOCAINE 10MG/ML, In a) 5 ML Vials and b) 10ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 7000 mL in Vials

M.I.C. 25/50/50 (PF) METHIONINE 25MG;INOSITOL 50MG;CHOLINE CHL 50MG/ML, In 2ML Vials, MEDAUS PHARMACY

D-1220-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: M.I.C. 25/50/50 (PF) METHIONINE 25MG;INOSITOL 50MG;CHOLINE CHL 50MG/ML, In 2ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 187 mL in Vials

THIAMINE 100 MG/ML, 2ML Vials, MEDAUS PHARMACY

D-1246-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: THIAMINE 100 MG/ML, 2ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 1000 mL in Vials

LIDOCAINE 2% (PF) IN NACL, 10ML Vials, MEDAUS PHARMACY

D-1200-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: LIDOCAINE 2% (PF) IN NACL, 10ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 147 mL in Vials

DMSO 99.9 (PF), In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY

D-1181-2016 · Class II · reported 2016-07-20 · Terminated

Why it was recalled: Lack of Assurance of Sterility
Product: DMSO 99.9 (PF), In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY
Where it went: U.S. Nationwide, Japan, and New Zealand.
How much: 2218 mL in Vials

Showing the 30 most recent of 96. The rest are searchable at the FDA enforcement report database.

Read these counts with three things in mind

A firm with more recalls usually makes more products. A contract packer runs hundreds of lines. It will out-recall a company with one product whatever either does. This is not a safety ranking.

Most recalls here are voluntary. A firm found its own fault and pulled the stock. That is the system working. It lands in this database looking the same as a recall the FDA had to push for.

Terminated means the FDA considers the recall finished. It is not a verdict. It does not mean anyone was harmed.

Source: openFDA enforcement reports, retrieved 2026-08-05. FDA dataset last updated 2026-07-29.

← All drug recalls